These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin. Gardinali M; Calcagno A; Conciato L; Agostoni A; Rosti A; Cori P; Vozzo N; Moroni A; Anelli A; Zoni U Int J Artif Organs; 1994 Jun; 17(6):337-44. PubMed ID: 7806419 [TBL] [Abstract][Full Text] [Related]
4. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients. Farrell J; Bastani B Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041 [No Abstract] [Full Text] [Related]
5. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797 [TBL] [Abstract][Full Text] [Related]
7. Effect of permeability on indices of haemodialysis membrane biocompatibility. Masaki T; Gilson J; Leypoldt JK; Cheung AK Nephrol Dial Transplant; 1999 May; 14(5):1176-81. PubMed ID: 10344358 [TBL] [Abstract][Full Text] [Related]
8. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes. Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054 [TBL] [Abstract][Full Text] [Related]
10. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study. Donati D; Degiannis D; Homer L; Raska K; Raskova J Am J Nephrol; 1991; 11(6):451-8. PubMed ID: 1819211 [TBL] [Abstract][Full Text] [Related]
11. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis. Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis. Patarca R; Perez G; Gonzalez A; Garcia-Morales RO; Gamble R; Klimas N; Fletcher MA Am J Nephrol; 1992; 12(4):274-8. PubMed ID: 1481878 [TBL] [Abstract][Full Text] [Related]
13. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure]. Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856 [TBL] [Abstract][Full Text] [Related]
14. Production of cytokines in hemodialysis. Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis. Schaefer RM; Gilge U; Goehl H; Heidland A Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889 [TBL] [Abstract][Full Text] [Related]
16. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes. Honkanen E; Grönhagen-Riska C; Teppo AM; Maury CP; Meri S Nephron; 1991; 57(3):283-7. PubMed ID: 2017267 [TBL] [Abstract][Full Text] [Related]
17. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Docci D; Capponcini C; Mengozzi S; Baldrati L; Neri L; Feletti C Nephron; 1995; 69(3):323-6. PubMed ID: 7753268 [TBL] [Abstract][Full Text] [Related]
18. Influence of dialysis membranes on the convective transport of middle molecules. De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117 [TBL] [Abstract][Full Text] [Related]
19. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets]. Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988 [TBL] [Abstract][Full Text] [Related]
20. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules. Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]